Aug 24 Life sciences company Precision
Therapeutics Inc filed with U.S. regulators on Friday to raise
up to $80.5 million in an initial public offering of common
JP Morgan Securities Inc, Piper Jaffray & Co and JMP
Securities LLC are underwriting the IPO, the Pittsburgh,
Pennsylvania-based company told the U.S. Securities and
Exchange Commission in a preliminary prospectus.
The company develops and commercializes tests intended to
assist physicians in individualizing cancer therapy. The filing
did not reveal how many shares the company planned to sell or
the expected price.
(Reporting by Dilipp S. Nag in Bangalore)